1![July 13, 2016 Post-Grant for Practitioners Midyear Review of Decisions and Developments at the PTAB July 13, 2016 Post-Grant for Practitioners Midyear Review of Decisions and Developments at the PTAB](https://www.pdfsearch.io/img/7a1bc647b6ac8af592517c0883280339.jpg) | Add to Reading ListSource URL: fishpostgrant.comLanguage: English - Date: 2016-07-14 09:55:09
|
---|
2![United States Court of Appeals for the Federal Circuit ______________________ GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP, United States Court of Appeals for the Federal Circuit ______________________ GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP,](https://www.pdfsearch.io/img/c1a89445927722d6410bb86af991ec53.jpg) | Add to Reading ListSource URL: www.patentchallenges.comLanguage: English - Date: 2016-08-09 02:08:12
|
---|
3![Muscular dystrophy / Biotechnology / Duchenne muscular dystrophy / Sarepta Therapeutics / PTC Therapeutics / Exon skipping / Clinical trial / BioMarin Pharmaceutical / Draft:BMN 044 / Draft:SRP-4044 Muscular dystrophy / Biotechnology / Duchenne muscular dystrophy / Sarepta Therapeutics / PTC Therapeutics / Exon skipping / Clinical trial / BioMarin Pharmaceutical / Draft:BMN 044 / Draft:SRP-4044](/pdf-icon.png) | Add to Reading ListSource URL: jettfoundation.orgLanguage: English - Date: 2016-01-26 12:45:27
|
---|
4![Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc](https://www.pdfsearch.io/img/1942231e593f78c72aff4dbdb6a164a3.jpg) | Add to Reading ListSource URL: files.shareholder.comLanguage: English |
---|
5![Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. ( Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. (](https://www.pdfsearch.io/img/a00eedf2282326fadd61aef4142d77b9.jpg) | Add to Reading ListSource URL: www.prosensa.euLanguage: English - Date: 2015-04-27 19:57:39
|
---|
6![May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im](https://www.pdfsearch.io/img/7ba1164d6b62603e3feb67c37e645719.jpg) | Add to Reading ListSource URL: www.apjohnventures.comLanguage: English - Date: 2014-05-29 15:30:33
|
---|
7![Microsoft Word - Apjohn Ventures Fund 2Q10 Letter Final Microsoft Word - Apjohn Ventures Fund 2Q10 Letter Final](https://www.pdfsearch.io/img/f50e1a77dccef4f91a3562c2aaea87b7.jpg) | Add to Reading ListSource URL: www.apjohnventures.comLanguage: English |
---|
8![TERMS OF USE Effective Date: April 27, 2015 These Terms of Use (“Terms”) govern your access to and use of the websites and online services that we operate and that link to these Terms (the “Services”). Please rev TERMS OF USE Effective Date: April 27, 2015 These Terms of Use (“Terms”) govern your access to and use of the websites and online services that we operate and that link to these Terms (the “Services”). Please rev](https://www.pdfsearch.io/img/5978f052ee29b4cb772e018e9e285903.jpg) | Add to Reading ListSource URL: www.bmrn.comLanguage: English - Date: 2015-04-27 19:57:43
|
---|
9![Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. ( Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. (](https://www.pdfsearch.io/img/aa6f2c8b00b41ce90322ddcf6b2ce4f5.jpg) | Add to Reading ListSource URL: www.bmrn.comLanguage: English - Date: 2015-04-27 19:57:39
|
---|
10![Microsoft Word - SanRafael_MD_42034_HWOL_0415.doc Microsoft Word - SanRafael_MD_42034_HWOL_0415.doc](https://www.pdfsearch.io/img/6e36ad4b3d8addbf5b4b691c2879859b.jpg) | Add to Reading ListSource URL: www.calmis.ca.govLanguage: English - Date: 2015-05-22 11:54:12
|
---|